|
|
Line 1: |
Line 1: |
| [[Image:1isf.jpg|left|200px]] | | {{Seed}} |
| | [[Image:1isf.png|left|200px]] |
|
| |
|
| <!-- | | <!-- |
Line 9: |
Line 10: |
| {{STRUCTURE_1isf| PDB=1isf | SCENE= }} | | {{STRUCTURE_1isf| PDB=1isf | SCENE= }} |
|
| |
|
| '''Crystal Structure Analysis of BST-1/CD157'''
| | ===Crystal Structure Analysis of BST-1/CD157=== |
|
| |
|
|
| |
|
| ==Overview==
| | <!-- |
| cADPR is the novel second messenger that elicits calcium release from intracellular calcium stores and works independently of IP(3). In mammals, the ADP-ribosyl cyclase function is found in two membrane proteins, CD38 and BST-1/CD157. These enzymes, exposed extracellularly, bear cADPR hydrolase and NAD glycohydrolase activities. In spite of its functional importance, the structural basis of these enzymatic reactions remains elusive. We determined the crystal structures of the extracellular region of human BST-1 at atomic resolution in the free form and in complexes with five substrate analogues: nicotinamide, NMN, ATPgammaS, ethenoNADP, and ethenoNAD. The three-dimensional structural views of the reaction centre with these ligands revealed the mode of substrate binding and the catalytic mechanism of the multifunctional enzymatic reactions. In each catalytic cleft of the dimeric enzyme, substrates are recognized predominantly through van der Waals interactions with two tryptophan residues, and thereby the N-glycosidic bond of NAD is correctly exposed near a catalytic glutamate residue. Its carboxyl side-chain stabilizes the catalytic intermediate of the S(N)-1 type reaction. This conformation of the catalytic cleft also implies the mechanism of cyclization between the adenine base and the ribose. The three key residues are invariant among the sequences of BST-1, CD38, and Aplysia cyclase, and hence this substrate recognition mode and catalytic scheme appear to be common in the cyclase family.
| | The line below this paragraph, {{ABSTRACT_PUBMED_11866528}}, adds the Publication Abstract to the page |
| | (as it appears on PubMed at http://www.pubmed.gov), where 11866528 is the PubMed ID number. |
| | --> |
| | {{ABSTRACT_PUBMED_11866528}} |
|
| |
|
| ==About this Structure== | | ==About this Structure== |
Line 31: |
Line 35: |
| [[Category: Cn]] | | [[Category: Cn]] |
| [[Category: Nad glycohydrolase]] | | [[Category: Nad glycohydrolase]] |
| ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May 2 20:21:30 2008'' | | |
| | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 1 13:55:20 2008'' |